Publications

Heading 5
Monitoring warfarin with factors II and X only

12

  • Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article.

  • Authors: Pall T. Onundarson , Ragnar Palsson, Daniel M. Witt and Brynja R. Gudmundsdottir

  • Thrombosis Journal open access Oct 2021

Heading 5
Monitoring warfarin with factors II and X only

11

Monitoring warfarin with factors II and X only
  • Ignoring instead of chasing after coagulation factor VII during warfarin management; an interrupted time series.

  • Authors: Alma R. Oskarsdottir, Brynja R. Gudmundsdottir, Hulda M. Jensdottir, Bjorn Flygenring, Ragnar Palsson, and Pall T. Onundarson

  • Blood May 30 2021

Heading 5
Monitoring warfarin with factors II and X only

11a

Heading 5
Monitoring warfarin with factors II and X only

10

  • Commentery

  • Author: Daniel M. Witt

  • Blood May 30 2021

Heading 5
The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin

9

 

Heading 5
Oral anticoagulant monitoring: Are we on the right track?

8

During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time
During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time

7

  • Authors: Jonsson PI, Letertre L, Juliusson SJ, Gudmundsdottir BR, Francis CW, Onundarson PT

  • J Thromb Haemost. 2017 jan;15(1):131-139. doi 10.1111/jth.13549. Pub 2016 Nov 30

Heading 5
Heading 5

6

  • Authors: Oskarsdottir AR, Gudmundsdottir BR, Indridason OS, Arnar DO, Bjornsson ES, Magnusson MK, Jensdottir HM, Vidarson B, Francis CW, Onundarson PT

  • J Thromb Thrombolysis. 2017 May;43(4):550-561. doi 10.1007/s11239-017-1482-4

Heading 5
Heading 5

5

  • A system review of randomised trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin

  • Authors: P.T. Onundarson, D.O. Arnar, S.H. Lund, B.R. Gudmundsdottir, C.W. Francis, O.S. Indridason

  • Version of Record online: 17 July 2016. DOI: 10.111/ijlh.12537

Heading 5
Heading 5

4

  • Authors: Letertre LR, Gudmundsdottir BR, Francis CW, Gosselin RC, Skeppholm M, Malmstrom RE, Moll S, Hawes E, Francart S, Onundarson PT

  • J Throm Haemost. 2016 May; 15(5):1043-53. DOI: 10.1111/jth.13300

Heading 5
Heading 5

3

  • Authors: Lippi G, Favaloro EJ.

  • The Lancet Hematology. 2015;2(6):2

Heading 5
Heading 5

2

  • Authors: Páll T Onundarson, Charles W Francis, Olafur S Indridason, David O Arnar, Einar S Bjornsson, Magnus K Mangusson, Sigurdur J Juliusson, Hulda M Jensdottir, Brynjar Vidarsson, Petur S Gunnarsson, Sigrun H Lund, Brynja R Gudmundsdottir

  • The Lancet Hematology. 2015;2(6):9

Heading 5
Heading 5

1

  • Authors: Brynja R. Gudmundsdottir, Charles W. Francis, Alexia M. Bjornsdottir, Moa Nellbring, Pall T. Onundarson

  • Thromb Res. 2012;130(4):674-81

11062b_f0cd2b56e86443d68d21b6bc12fe055c_

Let's Work Together

This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content.